Related Experiment Video
Updated: Aug 26, 2025

Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Published on: August 12, 2021
The SARS-CoV-2 specific IgG antibodies biophotonic sensor
Małgorzata Szczerska1, Paweł Wityk2, Paulina Listewnik1
1Department of Metrology and Optoelectronics, Faculty of Electronics, Telecommunications and Informatics, Gdańsk University of Technology, Gdańsk, Poland.
This article introduces a new light-based sensor designed to quickly identify specific antibodies against the virus that causes COVID-19. By using standard telecommunication fiber optics, the researchers created a device that can detect these proteins in very small liquid samples. The system provides results in under one minute, matching the levels typically found in human blood. This technology offers a potential tool for rapid health screening and monitoring.
Area of Science:
- Biophotonic sensor development within clinical diagnostics
- Immunoglobulin G detection systems in medical engineering
Background:
No prior work had resolved how to integrate standard telecommunication infrastructure for rapid viral antibody detection. Researchers often struggle with balancing sensitivity and speed in portable diagnostic platforms. It was already known that optical fibers offer unique advantages for miniaturized sensing applications. This gap motivated the development of a specialized device tailored for specific protein identification. Prior research has shown that surface modification allows for selective binding of target molecules. That uncertainty drove the need for a robust, fiber-based interface capable of real-time monitoring. Existing methods frequently require complex laboratory setups or long incubation times for accurate results. This study addresses these limitations by leveraging established fiber optic technology for clinical utility.
Purpose Of The Study:
The aim of this work is to present the design and operational principles of a specialized fiber-based diagnostic tool. Researchers sought to create a system capable of detecting specific viral antibodies. This project addresses the need for faster, more efficient methods for identifying immune responses. The team focused on utilizing standard telecommunication components to lower the complexity of diagnostic hardware. They intended to demonstrate that a modified fiber tip could serve as a sensitive sensing platform. The study explores whether bio-functionalization can provide the necessary selectivity for clinical applications. By testing the device with small sample volumes, the authors aimed to prove its practical utility. This effort highlights the potential for repurposing existing optical technologies for urgent health monitoring requirements.
Main Methods:
The team designed a sensing head directly onto the tip of a single-mode fiber-28. They utilized telecommunication-grade infrastructure to establish the optical pathway for signal transmission. The approach involved applying a specific bio-functionalization layer to the fiber surface. This coating ensures that only the target proteins bind to the sensor interface. The investigators performed preliminary evaluations using controlled liquid samples to verify performance. They monitored the optical response during the interaction between the sensor and the analyte. The experimental setup allowed for the precise delivery of five-microliter volumes to the active area. This methodology emphasizes the integration of standard optical components into a functional diagnostic tool.
Main Results:
The device successfully identifies target proteins in less than one minute. Testing confirms that a five-microliter sample volume is sufficient for accurate detection. The sensor maintains functionality at a concentration of ten micrograms per milliliter. This specific concentration level aligns with physiological values observed in human serum. The researchers report that the system can operate with even smaller liquid quantities than initially tested. These findings demonstrate the high sensitivity of the fiber-based interface. The data show that the bio-functionalized surface provides reliable detection under the specified conditions. The results validate the feasibility of using telecommunication fibers for rapid clinical screening.
Conclusions:
The authors propose that their fiber-based platform provides a viable alternative for rapid antibody screening. This synthesis suggests that the device maintains high sensitivity despite its small physical footprint. The researchers claim that the system successfully identifies target proteins within a minute. Their findings indicate that the sensor functions effectively at concentrations relevant to human serum. The study implies that bio-functionalization of fiber faces enables high selectivity for specific viral markers. These results demonstrate the potential for integrating telecommunication components into medical diagnostic tools. The authors conclude that the platform supports miniaturized, high-speed testing requirements. Future applications may benefit from the portability and efficiency demonstrated by this specific optical configuration.
Frequently Asked Questions
The researchers propose that the device utilizes light-based detection on a modified fiber face. This mechanism identifies specific proteins by measuring changes in optical properties upon binding, allowing for rapid detection within sixty seconds.
The team employs single-mode fiber-28, a standard telecommunication component. This tool serves as the physical foundation for the sensor head, enabling the integration of light-based sensing with biological sample analysis.
The authors state that the fiber face requires bio-functionalization to ensure selectivity. This technical necessity allows the surface to specifically capture the target proteins while ignoring other substances present in the sample.
The researchers use a five-microliter liquid volume for their testing. This small sample size is sufficient to achieve accurate detection, demonstrating the efficiency of the device in handling limited biological material.
The team measures antibody concentrations at ten micrograms per milliliter. This specific value corresponds to typical levels found in human serum, confirming the clinical relevance of the sensor for real-world diagnostic applications.
The researchers propose that this technology enables rapid, portable screening. They claim the system offers a significant improvement in testing speed compared to conventional laboratory methods, potentially facilitating faster clinical decision-making.
More Related Videos
07:08A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
Published on: April 6, 2021
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021